- Home
- Solutions
- Laboratories
- Bioanalytical Laboratories
- Ligand Binding Assays
Ligand Binding Assays
ICON develops sensitive and specific GLP compliant immunoassays to support the research and development of macromolecules for PK, biomarkers and immunogenicity studies. Assay development can be customised to meet client needs and direct, indirect, capture and competitive LBA formats are available.
The platforms include absorbance, chemiluminescence and electrochemiluminescence. ICON has ELISA plate readers, MSD SQ120 instruments and Ella readers at all of our bioanalytical laboratories. At some locations, Gyrolab Workstations and SMCxPro for high-sensitivity needs are available.
We also provide high throughput immunoassay support for drug development using assay formats developed internally or provided by the client. Our facilities employ state-of-the-art automated liquid handling systems to increase accuracy and precision and decrease turnaround time.
In this section
-
Blended Solutions
- Asset Development Consulting
-
Cardiac Safety Solutions
-
Clinical & Scientific Operations
- Biostatistics
-
Case studies
- Clinical Operations
-
Clinical Supplies Management
- COVID-19
- Clinical data science
-
Endpoint Adjudication Services
- Global Logistics
- Interactive Response Technology
- Investigator Payments
-
Medical Affairs
-
Medical Call Centre Services
-
Medical Writing & Publishing
- Pharmacovigilance
-
Project and Program Management
-
Site Identification and Feasibility
- Commercial Positioning
- Decentralised Clinical Trials
- Language Services
- Early Clinical
- Real World Intelligence
- Strategic Solutions
- Regulatory Affairs
-
Laboratories
- Symphony Health data
- Medical Imaging
-
Technologies
-
Decentralised Clinical Trial Solutions
- Site & Patient Solutions